Stock Events

Ekso Bionics 

$1.19
39
+$0.06+5.31% Friday 20:00

Statistics

Day High
1.19
Day Low
1.1
52W High
3.13
52W Low
0.62
Volume
27,614
Avg. Volume
44,656
Mkt Cap
21.63M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

29AprConfirmed
Q2 2022
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.33
-0.26
-0.18
-0.11
Expected EPS
-0.16
Actual EPS
-0.2

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EKSO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Resmed
RMD
Mkt Cap28.61B
ResMed Inc. competes in the development, manufacturing, and marketing of medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders, including sleep apnea, a field closely related to Ekso Bionics' focus on medical devices for physical assistance.
Community Health Systems
CYH
Mkt Cap459.98M
Community Health Systems, Inc. operates hospitals and healthcare facilities, which could be potential users of Ekso Bionics' medical devices, making them indirect competitors in the healthcare solutions market.
Zimmer Biomet
ZBH
Mkt Cap22.22B
Zimmer Biomet Holdings, Inc. manufactures and markets orthopedic reconstructive products, competing with Ekso Bionics in the broader market for medical devices that aid mobility.
Smith & Nephew
SNN
Mkt Cap11.72B
Smith & Nephew plc designs, manufactures, and markets medical devices for the orthopedic market, competing with Ekso Bionics in the development of technologies for physical rehabilitation.
Medtronic
MDT
Mkt Cap99.52B
Medtronic plc specializes in medical technologies, services, and solutions, including those for spinal and musculoskeletal conditions, making it a competitor in the medical device market alongside Ekso Bionics.
Stryker
SYK
Mkt Cap128.48B
Stryker Corporation specializes in medical technologies, including orthopedics, making it a competitor in the market for devices that support physical mobility and rehabilitation.
Globus Medical
GMED
Mkt Cap7.74B
Globus Medical, Inc. focuses on musculoskeletal solutions, directly competing with Ekso Bionics in the development and marketing of medical devices aimed at improving physical mobility.
Boston Scientific
BSX
Mkt Cap112.32B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing indirectly with Ekson Bionics by offering alternative solutions for patient care.
Hologic
HOLX
Mkt Cap17.29B
Hologic, Inc. specializes in medical devices for diagnostics, surgery, and women's health, indirectly competing with Ekso Bionics by providing alternative medical technologies that could be used in patient rehabilitation and care.

Analyst Ratings

6.25$Average Price Target
The highest estimate is $10.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

About

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.
Show more...
CEO
Jack Peurach
Employees
70
Country
US
ISIN
US2826443010
WKN
000A2P19Y

Listings